CN103961491A - Traditional Chinese medicine for treating amblyopia - Google Patents

Traditional Chinese medicine for treating amblyopia Download PDF

Info

Publication number
CN103961491A
CN103961491A CN201410224191.XA CN201410224191A CN103961491A CN 103961491 A CN103961491 A CN 103961491A CN 201410224191 A CN201410224191 A CN 201410224191A CN 103961491 A CN103961491 A CN 103961491A
Authority
CN
China
Prior art keywords
parts
grams
chinese medicine
radix
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410224191.XA
Other languages
Chinese (zh)
Inventor
刘艳菊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinan Weichuan Information Technology Co Ltd
Original Assignee
Jinan Weichuan Information Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinan Weichuan Information Technology Co Ltd filed Critical Jinan Weichuan Information Technology Co Ltd
Priority to CN201410224191.XA priority Critical patent/CN103961491A/en
Publication of CN103961491A publication Critical patent/CN103961491A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to a traditional Chinese medicine, and particularly relates to a traditional Chinese medicine for treating amblyopia. The traditional Chinese medicine for treating amblyopia is characterized by being mainly prepared from the following raw materials in parts by weight: 2-5 parts of mint, 2-5 parts of chrysanthemum, 1-3 parts of astragalus membranaceus, 2-4 parts of angelica sinensis, 2-5 parts of mulberry leaf, 1-4 parts of concha haliotidis, 1-3 parts of salviae miltiorrhizae, 2-4 parts of ecristate corydalis herb, 2-5 parts of three-coloured amaranth seed, 3-6 parts of smallflower galinsoga flower, 2-3 parts of spina date seed, 2-5 parts of japanese raspberry root, 3-4 parts of achyranthes root, 1-3 parts of self heal, 2-3 parts of pulp of dogwood fruit, 1-2 parts of mimosa pudica, 1-4 parts of radix bupleuri, 3-6 parts of patrinia scaniosaefolia, 1-3 parts of rhizoma acori graminei, 2-3 parts of poria cocos and 2-5 parts of cistanche salsa. The traditional Chinese medicine is significant in curative effect, has the effects of nourishing yin, nourishing the liver and improving eyesight, and is free of toxic and side effects, the eye development process of a sufferer is improved, the living quality of a patient is improved, the patient can be secure to take, and the total effective rate can be up to 98%.

Description

A kind of Chinese medicine for the treatment of amblyopia
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicine for the treatment of amblyopia.
(1) background technology
All eyes without organic disease, correcting defects of vision is called amblyopia lower than 0.9.Amblyopia is the common eye diseases in children of clinical ophthalmology, sickness rate is 3% left and right, it is infant period, because a variety of causes fails to accept the suitable stimulation of looking as reasons such as consciousness, motion, conduction and the visual center, the state that the visual performance that visual development is affected and occur goes down, main manifestations is visual disturbance and binocular vision obstacle, amblyopia is not only damaged child's vision, and can make child lose stereoscopic vision, multiple occupation and the work post such as not competent high-tech area after growing up.Cause is the fastest period of visual development in critical period (before 3 years old) and the sensitive period (6~8 years old) of visual development; also be that vision is suffering abnormal environment to stimulate the period that the most easily produces permanent lesion simultaneously; therefore, timely correction of refractive errors, anisometropia, stravismus and to remove visual deprivation factor be the basic way that prevention amblyopia occurs within critical period of visual development and sensitive period.
In recent years, the traditional Chinese medical science is cured amblyopia and has been obtained certain effect, and the Integral Concept of the traditional Chinese medical science and dialectical treating have been brought into play good effect, are more and more approved by people.
(2) summary of the invention
The Chinese medicine of the treatment amblyopia that the invention provides a kind of good effect, fill a prescription rationally, has no side effect.
The present invention is achieved through the following technical solutions:
Treat a medicine for amblyopia, its special character is: the raw material composition that mainly contains following weight fraction:
2 ~ 5 parts of Herba Menthaes, 2 ~ 5 parts of Flos Chrysanthemis, 1 ~ 3 part of the Radix Astragali,
2 ~ 4 parts of Radix Angelicae Sinensis, 2 ~ 5 parts, Folium Mori, 1 ~ 4 part of Concha Haliotidis,
1 ~ 3 part of Radix Salviae Miltiorrhizae, 2 ~ 4 parts of Herba Corydalis tailensiss, 2 ~ 5 parts of Semen Amaranthi tricoloris,
3 ~ 6 parts of Flos Galinsogae Parvifloraes, 2 ~ 3 parts of Semen Ziziphi Spinosaes, 2 ~ 5 parts of Radix Rubi Parvifoliis,
3 ~ 4 parts of Radix Achyranthis Bidentataes, 1 ~ 3 part of Spica Prunellae, 2 ~ 3 parts of Fructus Corni,
1 ~ 2 part of Herba Mimosae Pudicae, 1 ~ 4 part of Radix Bupleuri, 3 ~ 6 parts of Herba Patriniaes,
1 ~ 3 part of Rhizoma Acori Graminei, 2 ~ 3 parts, Poria, 2 ~ 5 parts of Herba Cistanches.
Compound method of the present invention is as follows: medicinal boiled water immersion in above-mentioned was decocted after 1 hour, and when decoction, moisture content exceedes Chinese medicine 3-5 centimetre, uses slow fire boiling after 40 minutes after water seethes with excitement, and filtration is poured out medicinal liquid and can be taken, point morning and evening, twice on the one.
1, clinical observation:
(1) physical data:
The inventor in 2010 so far, chooses 158 routine patients and carries out clinical observation treatment.Age 6 is to 22 years old, wherein male 81 examples, female's 77 examples.
(2) Therapeutic Method:
With being decocted in water for oral dose, sooner or later respectively once, it within 30 days, is a course for the treatment of with medicine of the present invention, according to the state of an illness and do not recover speed treatment 1-10 month not etc.
(3) efficacy assessment standard:
The present invention is mainly used in treating amblyopia, therefore amblyopia symptom improvement situation and every detection index are as curative effect judging standard, is divided into following four kinds:
Cure: clinical symptom disappearance, vision restoration are more than 0.8.
Effective: clinical symptom disappearance, vision is obviously improved.
Effective: clinical symptoms, vision are all improved.
Invalid: clinical symptoms and vision are unchanged.
(4) therapeutic effect:
Cure 141 examples, effective 10 examples, effective 5 examples, invalid 2 examples, all cases all have no adverse reaction.
The present invention is evident in efficacy, have YIN nourishing, nourishing the liver, improving eyesight effect, improve patient's eye developmental process, improved patient's quality of life; And it has no side effect, patient can feel at ease to take, and total effective rate reaches 98%.
Detailed description of the invention
Embodiment 1:
By 2 grams of Herba Menthaes, 2 grams of Flos Chrysanthemis, 1 gram of the Radix Astragali, 2 grams of Radix Angelicae Sinensis, 2 grams, Folium Mori, 1 gram of Concha Haliotidis, 1 gram of Radix Salviae Miltiorrhizae, 2 grams of Herba Corydalis tailensiss, 2 grams of Semen Amaranthi tricoloris, 3 grams of Flos Galinsogae Parvifloraes, 2 grams of parts of Semen Ziziphi Spinosae, 2 grams of Radix Rubi Parvifoliis, 3 grams of Radix Achyranthis Bidentataes, 1 gram of Spica Prunellae, 2 grams of Fructus Corni, 1 gram of Herba Mimosae Pudicae, 1 gram of Radix Bupleuri, 3 grams of Herba Patriniaes, 1 gram of Rhizoma Acori Graminei, 2 grams, Poria, 2 grams of Herba Cistanches soak after 1 hour and decoct with boiled water, and when decoction, moisture content exceedes 3 centimeters, Chinese medicine, after water boiling, use slow fire boiling after 40 minutes, filtration is poured out medicinal liquid and can be taken, point morning and evening, twice on the one.
Embodiment 2:
By 3 grams of Herba Menthaes, 3 grams of Flos Chrysanthemis, 2 grams of the Radixs Astragali, 3 grams of Radix Angelicae Sinensis, 3 grams, Folium Mori, 3 grams of Concha Haliotidis, 2 grams of Radix Salviae Miltiorrhizaes, 3 grams of Herba Corydalis tailensiss, 3 grams of Semen Amaranthi tricoloris, 4 grams of Flos Galinsogae Parvifloraes, 3 grams of Semen Ziziphi Spinosaes, 3 grams of Radix Rubi Parvifoliis, 4 grams of Radix Achyranthis Bidentataes, 2 grams of Spica Prunellaes, 3 grams of Fructus Corni, 2 grams of Herba Mimosae Pudicaes, 3 grams of Radix Bupleuri, 5 grams of Herba Patriniaes, 2 grams of Rhizoma Acori Graminei, 3 grams, Poria, 3 grams of Herba Cistanches soak after 1 hour and decoct with boiled water, and when decoction, moisture content exceedes 4 centimeters, Chinese medicine, after water boiling, use slow fire boiling after 40 minutes, filtration is poured out medicinal liquid and can be taken, point morning and evening, twice on the one.
Embodiment 3:
By 5 grams of Herba Menthaes, 5 grams of Flos Chrysanthemis, 3 grams of the Radixs Astragali, 4 grams of Radix Angelicae Sinensis, 5 grams, Folium Mori, 4 grams of Concha Haliotidis, 3 grams of Radix Salviae Miltiorrhizaes, 4 grams of Herba Corydalis tailensiss, 5 grams of Semen Amaranthi tricoloris, 6 grams of Flos Galinsogae Parvifloraes, 3 grams of Semen Ziziphi Spinosaes, 5 grams of Radix Rubi Parvifoliis, 4 grams of Radix Achyranthis Bidentataes, 3 grams of Spica Prunellaes, 3 grams of Fructus Corni, 2 grams of Herba Mimosae Pudicaes, 4 grams of Radix Bupleuri, 6 grams of Herba Patriniaes, 3 grams of Rhizoma Acori Graminei, 3 grams, Poria, 5 grams of Herba Cistanches soak after 1 hour and decoct with boiled water, and when decoction, moisture content exceedes 5 centimeters, Chinese medicine, after water boiling, use slow fire boiling after 40 minutes, filtration is poured out medicinal liquid and can be taken, point morning and evening, twice on the one.

Claims (1)

1. a Chinese medicine for the treatment of amblyopia, is characterized in that: the raw material composition that mainly contains following weight fraction:
2 ~ 5 parts of Herba Menthaes, 2 ~ 5 parts of Flos Chrysanthemis, 1 ~ 3 part of the Radix Astragali,
2 ~ 4 parts of Radix Angelicae Sinensis, 2 ~ 5 parts, Folium Mori, 1 ~ 4 part of Concha Haliotidis,
1 ~ 3 part of Radix Salviae Miltiorrhizae, 2 ~ 4 parts of Herba Corydalis tailensiss, 2 ~ 5 parts of Semen Amaranthi tricoloris,
3 ~ 6 parts of Flos Galinsogae Parvifloraes, 2 ~ 3 parts of Semen Ziziphi Spinosaes, 2 ~ 5 parts of Radix Rubi Parvifoliis,
3 ~ 4 parts of Radix Achyranthis Bidentataes, 1 ~ 3 part of Spica Prunellae, 2 ~ 3 parts of Fructus Corni,
1 ~ 2 part of Herba Mimosae Pudicae, 1 ~ 4 part of Radix Bupleuri, 3 ~ 6 parts of Herba Patriniaes,
1 ~ 3 part of Rhizoma Acori Graminei, 2 ~ 3 parts, Poria, 2 ~ 5 parts of Herba Cistanches.
CN201410224191.XA 2014-05-26 2014-05-26 Traditional Chinese medicine for treating amblyopia Pending CN103961491A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410224191.XA CN103961491A (en) 2014-05-26 2014-05-26 Traditional Chinese medicine for treating amblyopia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410224191.XA CN103961491A (en) 2014-05-26 2014-05-26 Traditional Chinese medicine for treating amblyopia

Publications (1)

Publication Number Publication Date
CN103961491A true CN103961491A (en) 2014-08-06

Family

ID=51231811

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410224191.XA Pending CN103961491A (en) 2014-05-26 2014-05-26 Traditional Chinese medicine for treating amblyopia

Country Status (1)

Country Link
CN (1) CN103961491A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105851362A (en) * 2016-03-30 2016-08-17 黄山树德堂食品饮料有限公司 Blood nourishing and kidney benefiting, and liver clearing and eyesight improving chrysanthemum health-care tea and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1178682A (en) * 1996-10-07 1998-04-15 郭书文 Chinese drug Mingmudan pill for improving eyesight and its producing method
KR20110054579A (en) * 2009-11-18 2011-05-25 강홍구 Herbal medicine composite and pill for ophthalmic fatigue relief and eyesight recovery

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1178682A (en) * 1996-10-07 1998-04-15 郭书文 Chinese drug Mingmudan pill for improving eyesight and its producing method
KR20110054579A (en) * 2009-11-18 2011-05-25 강홍구 Herbal medicine composite and pill for ophthalmic fatigue relief and eyesight recovery

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105851362A (en) * 2016-03-30 2016-08-17 黄山树德堂食品饮料有限公司 Blood nourishing and kidney benefiting, and liver clearing and eyesight improving chrysanthemum health-care tea and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102512603B (en) Traditional Chinese medicinal composition for treating acute infectious conjunctivitis
CN101559195B (en) Epilepsy therapy capsule and preparation method thereof
CN101954028A (en) Medicinal pillow for preventing and treating myopic eyes
CN100364593C (en) Oral liquid for promoting eyesight and protecting eye
CN103735790A (en) Traditional Chinese medicine composition for treating tinnitus
CN102670993B (en) Traditional Chinese medicine for treating cataract
CN102091214A (en) Medicament for improving eyesight
CN103961531A (en) Traditional Chinese medicine for treating palpitation
CN103961491A (en) Traditional Chinese medicine for treating amblyopia
CN102000279B (en) Traditional Chinese medicine for treating myopia eye diseases
CN101797314B (en) Medicinal composition for treating adolescent myopia and preparation method thereof
CN103720922A (en) Traditional Chinese medicinal decoction for treating keratitis
CN102813757B (en) Preparation method of traditional Chinese medicine for treating lumbago type acute glomerulonephritis
CN105596544A (en) Improved capsules capable of tonifying liver and improving eyesight
CN103721020A (en) Blood circulation promoting and meridian unlocking granule for treating cerebral thrombosis and preparation method of granule
CN107715095A (en) A kind of Chinese medicine preparation for treating paediatrics cough with lung heat
CN104189623A (en) Traditional Chinese medicine used for treating trachoma
CN104258295A (en) Traditional Chinese medicine decoction for treating lymphoma
CN115444903A (en) Application of rehabilitation eyesight oral liquid in preparation of eyesight improving medicine
CN103961492A (en) Traditional Chinese medicine for treating glaucoma
CN102727675B (en) Traditional Chinese medicine capsules used for treating nasal sinusitis
CN101843786A (en) Chinese medicament for treating diabetic eyeground pathological changes
CN105288229A (en) Traditional Chinese medicine composition for treating nystagmus
CN103977287A (en) Traditional Chinese medicine for treating viral myocarditis
CN105687775A (en) Traditional Chinese medicine composition for treating keratohelcosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20140806

RJ01 Rejection of invention patent application after publication